Literature DB >> 18259104

Septo-optic dysplasia - novel insights into the aetiology.

Daniel Kelberman1, Mehul Tulsidas Dattani.   

Abstract

Septo-optic dysplasia (SOD) is a highly heterogeneous condition comprising a variable phenotype of optic nerve hypoplasia, midline brain abnormalities and pituitary hypoplasia with consequent endocrine deficits. The majority of cases are sporadic and several aetiologies have been suggested to account for the pathogenesis of the condition. However, a number of familial cases have been described and the identification of mutations in key developmental genes including HESX1, SOX2 and SOX3 in patients with SOD and associated phenotypes suggests that a genetic causation is likely in the more common sporadic cases of the condition. The precise aetiology of SOD is most likely multifactorial involving contributions from environmental factors in addition to an important role for crucial developmental genes. The variability of the penetrance and phenotypes within a single SOD pedigree may also suggest a complex interaction between genetics and the environment, and at present, the understanding of these interactions is rudimentary. Further study of these critical factors may shed light on the aetiology of this complex disorder. We have reviewed recent literature selecting relevant references based on the keywords HESX1, SOX2, SOX3, Septo-optic dysplasia, genetics and pituitary development. (c) 2008 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18259104     DOI: 10.1159/000114856

Source DB:  PubMed          Journal:  Horm Res        ISSN: 0301-0163


  33 in total

1.  Outcome of fetuses with cerebral ventriculomegaly and septum pellucidum leaflet abnormalities.

Authors:  Yi Li; Rakhee K Sansgiri; Judy A Estroff; Tejas S Mehta; Tina Y Poussaint; Richard L Robertson; Caroline D Robson; Henry A Feldman; Carol Barnewolt; Deborah Levine
Journal:  AJR Am J Roentgenol       Date:  2011-01       Impact factor: 3.959

2.  Macular optical coherence tomography in patients with unilateral optic nerve hypoplasia.

Authors:  Javaneh Abbasian; Norman Blair; Mahnaz Shahidi; Gui-Shuaung Ying; Jiayan Huang; Lawrence Kaufman; Michael Blair
Journal:  J AAPOS       Date:  2015-02       Impact factor: 1.220

Review 3.  Prenatal determinants of optic nerve hypoplasia: review of suggested correlates and future focus.

Authors:  Pamela Garcia-Filion; Mark Borchert
Journal:  Surv Ophthalmol       Date:  2013 Nov-Dec       Impact factor: 6.048

Review 4.  Septo-optic dysplasia.

Authors:  Emma A Webb; Mehul T Dattani
Journal:  Eur J Hum Genet       Date:  2009-07-22       Impact factor: 4.246

Review 5.  The role of homeodomain transcription factors in heritable pituitary disease.

Authors:  Kelly L Prince; Emily C Walvoord; Simon J Rhodes
Journal:  Nat Rev Endocrinol       Date:  2011-07-26       Impact factor: 43.330

6.  Septo-optic Dysplasia Complex with Omphalocele, Pre-maxillary Agenesis and Encephalocele.

Authors:  Abdul Majeed Kavarodi; Khalid Zharani; El-Sayed Ali; Hussain Sharahili
Journal:  J Maxillofac Oral Surg       Date:  2014-08-03

7.  A new imaging entity consistent with partial ectopic posterior pituitary gland: report of six cases.

Authors:  Marina Ybarra; Rawan Hafiz; Marie-Eve Robinson; Julia Elisabeth von Oettingen; Helen Bui; Christine Saint-Martin
Journal:  Pediatr Radiol       Date:  2019-08-30

8.  Optic nerve hypoplasia syndrome: a review of the epidemiology and clinical associations.

Authors:  Pamela Garcia-Filion; Mark Borchert
Journal:  Curr Treat Options Neurol       Date:  2013-02       Impact factor: 3.598

9.  Effects of genetic variability of the caprine homeobox transcription factor HESX1 gene on performance traits.

Authors:  Xianyong Lan; Xinsheng Lai; Zhuanjian Li; Jing Wang; Chuzhao Lei; Hong Chen
Journal:  Mol Biol Rep       Date:  2009-07-23       Impact factor: 2.316

10.  Septo-optic dysplasia: fitting the pieces together.

Authors:  Nélia Ferraria; Sofia Castro; Daniela Amaral; Lurdes Lopes
Journal:  BMJ Case Rep       Date:  2013-05-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.